Theratechnologies (TH) Set to Announce Earnings on Thursday

Theratechnologies (TSE:TH) is scheduled to be issuing its quarterly earnings data before the market opens on Thursday, October 10th.

Theratechnologies (TSE:TH) last issued its quarterly earnings data on Wednesday, July 10th. The company reported C$0.03 earnings per share (EPS) for the quarter. The firm had revenue of C$30.00 million during the quarter. Theratechnologies had a negative return on equity of 1,116.86% and a negative net margin of 8.47%.

Theratechnologies Price Performance

Shares of TH stock opened at C$1.63 on Wednesday. The stock’s fifty day moving average is C$1.75 and its 200-day moving average is C$1.83. The company has a debt-to-equity ratio of 562.07, a quick ratio of 0.64 and a current ratio of 1.10. Theratechnologies has a 52 week low of C$1.27 and a 52 week high of C$3.43. The stock has a market capitalization of C$74.95 million, a PE ratio of -9.06, a PEG ratio of -8.50 and a beta of 1.73.

Theratechnologies Company Profile

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.